Farmers Trust Co. Boosts Stock Position in The Procter & Gamble Company (NYSE:PG)

Farmers Trust Co. grew its stake in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 1.3% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 37,836 shares of the company’s stock after buying an additional 477 shares during the period. Procter & Gamble accounts for 1.2% of Farmers Trust Co.’s portfolio, making the stock its 22nd biggest holding. Farmers Trust Co.’s holdings in Procter & Gamble were worth $6,139,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in PG. Norges Bank purchased a new position in Procter & Gamble in the 4th quarter worth approximately $3,956,117,000. Cerity Partners LLC lifted its holdings in Procter & Gamble by 106.2% in the 4th quarter. Cerity Partners LLC now owns 6,134,455 shares of the company’s stock worth $898,943,000 after purchasing an additional 3,159,796 shares in the last quarter. Wellington Management Group LLP increased its stake in Procter & Gamble by 9.4% in the 3rd quarter. Wellington Management Group LLP now owns 35,608,913 shares of the company’s stock worth $5,193,916,000 after acquiring an additional 3,047,557 shares during the last quarter. International Assets Investment Management LLC increased its stake in Procter & Gamble by 13,850.3% in the 4th quarter. International Assets Investment Management LLC now owns 2,747,379 shares of the company’s stock worth $402,601,000 after acquiring an additional 2,727,685 shares during the last quarter. Finally, Assenagon Asset Management S.A. increased its stake in Procter & Gamble by 235.8% in the 4th quarter. Assenagon Asset Management S.A. now owns 3,231,032 shares of the company’s stock worth $473,475,000 after acquiring an additional 2,268,805 shares during the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.

Procter & Gamble Price Performance

PG opened at $167.73 on Friday. The Procter & Gamble Company has a 12-month low of $141.45 and a 12-month high of $168.97. The company has a current ratio of 0.69, a quick ratio of 0.48 and a debt-to-equity ratio of 0.49. The business’s fifty day simple moving average is $164.33 and its 200-day simple moving average is $157.89. The company has a market capitalization of $395.87 billion, a price-to-earnings ratio of 27.41, a PEG ratio of 3.42 and a beta of 0.42.

Procter & Gamble (NYSE:PGGet Free Report) last posted its quarterly earnings results on Friday, April 19th. The company reported $1.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.42 by $0.10. Procter & Gamble had a return on equity of 33.91% and a net margin of 18.00%. The business had revenue of $20.20 billion for the quarter, compared to the consensus estimate of $20.43 billion. During the same quarter in the prior year, the company earned $1.37 EPS. The business’s revenue was up .6% compared to the same quarter last year. On average, equities research analysts anticipate that The Procter & Gamble Company will post 6.55 earnings per share for the current fiscal year.

Procter & Gamble Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, May 15th. Investors of record on Friday, April 19th were given a dividend of $1.0065 per share. The ex-dividend date was Thursday, April 18th. This represents a $4.03 dividend on an annualized basis and a yield of 2.40%. This is an increase from Procter & Gamble’s previous quarterly dividend of $0.94. Procter & Gamble’s dividend payout ratio (DPR) is presently 65.85%.

Analyst Upgrades and Downgrades

PG has been the topic of a number of research reports. Jefferies Financial Group lifted their price objective on Procter & Gamble from $175.00 to $182.00 and gave the stock a “buy” rating in a research note on Monday, April 22nd. The Goldman Sachs Group started coverage on Procter & Gamble in a research report on Friday, March 1st. They set a “neutral” rating and a $168.00 target price on the stock. Truist Financial raised Procter & Gamble from a “hold” rating to a “buy” rating and boosted their target price for the company from $160.00 to $175.00 in a research report on Monday, March 11th. Deutsche Bank Aktiengesellschaft cut their target price on Procter & Gamble from $172.00 to $171.00 and set a “buy” rating on the stock in a research report on Monday, April 22nd. Finally, Argus boosted their target price on Procter & Gamble from $180.00 to $185.00 and gave the company a “buy” rating in a research report on Thursday, April 25th. Seven analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $169.76.

Check Out Our Latest Research Report on PG

Insider Activity at Procter & Gamble

In related news, CEO R. Alexandra Keith sold 855 shares of the firm’s stock in a transaction dated Monday, April 22nd. The stock was sold at an average price of $158.50, for a total transaction of $135,517.50. Following the sale, the chief executive officer now owns 4,004 shares of the company’s stock, valued at $634,634. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other Procter & Gamble news, insider Balaji Purushothaman sold 28,369 shares of the firm’s stock in a transaction dated Tuesday, April 23rd. The stock was sold at an average price of $161.49, for a total value of $4,581,309.81. Following the completion of the sale, the insider now owns 11,507 shares of the company’s stock, valued at $1,858,265.43. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO R. Alexandra Keith sold 855 shares of the firm’s stock in a transaction dated Monday, April 22nd. The stock was sold at an average price of $158.50, for a total value of $135,517.50. Following the completion of the sale, the chief executive officer now directly owns 4,004 shares of the company’s stock, valued at approximately $634,634. The disclosure for this sale can be found here. Insiders have sold a total of 154,544 shares of company stock valued at $25,413,051 over the last quarter. 0.17% of the stock is owned by corporate insiders.

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

See Also

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.